INDV (STOCKS)
Indivior Pharmaceuticals, Inc. Common Stock
$38.400000
-0.080000 (-0.21%)
Prev close: $38.480000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Joseph J. Ciaffoni
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,792.42M
- Employees
- 1,051
- P/E (TTM)
- 19.45
- P/B (TTM)
- -32.53
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.24B |
| Benefits Costs and Expenses | $1.00B |
| Cost Of Revenue | $246.00M |
| Costs And Expenses | $1.00B |
| Gross Profit | $994.00M |
| Operating Expenses | $732.00M |
| Selling, General, and Administrative Expenses | $634.00M |
| Other Operating Expenses | $98.00M |
| Operating Income/Loss | $262.00M |
| Income/Loss From Continuing Operations After Tax | $210.00M |
| Income/Loss From Continuing Operations Before Tax | $239.00M |
| Income Tax Expense/Benefit | $29.00M |
| Income Tax Expense/Benefit, Current | $75.00M |
| Income Tax Expense/Benefit, Deferred | -$46.00M |
| Net Income/Loss | $210.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $210.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $210.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.68 |
| Diluted Earnings Per Share | $1.64 |
| Basic Average Shares | 125,000,000 |
| Diluted Average Shares | 128,000,000 |
| Assets | $1.20B |
| Current Assets | $652.00M |
| Inventory | $153.00M |
| Prepaid Expenses | $34.00M |
| Other Current Assets | $465.00M |
| Noncurrent Assets | $549.00M |
| Fixed Assets | $144.00M |
| Other Non-current Assets | $405.00M |
| Liabilities | $1.30B |
| Current Liabilities | $914.00M |
| Accounts Payable | $48.00M |
| Wages | $103.00M |
| Other Current Liabilities | $763.00M |
| Noncurrent Liabilities | $386.00M |
| Equity | -$98.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$98.00M |
| Liabilities And Equity | $1.20B |
| Net Cash Flow From Operating Activities | -$27.00M |
| Net Cash Flow From Operating Activities, Continuing | -$27.00M |
| Net Cash Flow From Investing Activities | -$66.00M |
| Net Cash Flow From Investing Activities, Continuing | -$66.00M |
| Net Cash Flow From Financing Activities | -$30.00M |
| Net Cash Flow From Financing Activities, Continuing | -$30.00M |
| Net Cash Flow | -$123.00M |
| Net Cash Flow, Continuing | -$123.00M |
| Comprehensive Income/Loss | $216.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $216.00M |
| Other Comprehensive Income/Loss | $216.00M |
| Other Comprehensive Income/Loss Attributable To Parent | $6.00M |